Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma

被引:0
|
作者
Tomoko Yamagishi
Katsuhiko Shimizu
Nobuaki Ochi
Hiromichi Yamane
Isao Irei
Yoshito Sadahira
Nagio Takigawa
Mikio Oka
Masao Nakata
机构
[1] Kawasaki Medical School,Department of General Internal Medicine 4
[2] Kawasaki Medical School,Department of General Thoracic Surgery
[3] Kawasaki Medical School,Department of Pathology
[4] Kawasaki Medical School,Department of Respiratory Medicine
来源
关键词
Epidermal Growth Factor Receptor; Gefitinib; Pemetrexed; Epidermal Growth Factor Receptor Mutation; Concordance Rate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS
    Guisier, Florian
    Salauen, Mathieu
    Lachkar, Samy
    Lamy, Aude
    Piton, Nicolas
    Obstoy, Berengere
    Sabourin, Jean-Christophe
    Thiberville, Luc
    RESPIROLOGY, 2016, 21 (04) : 718 - 726
  • [42] A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
    Naoki, Katsuhiko
    Takeda, Yuichiro
    Soejima, Kenzo
    Arai, Daisuke
    Naka, Go
    Nagase, Seisuke
    Arirnura, Ken
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Ikeda, Norihiko
    ONCOLOGY LETTERS, 2017, 13 (05) : 3285 - 3290
  • [43] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Yanhui Wan
    Youhui Qian
    Youyu Wang
    Fuyuan Fang
    Guodong Wu
    Discover Oncology, 13
  • [44] PemetrexedA Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer
    Claudine M. Baldwin
    Caroline M. Perry
    Drugs, 2009, 69 : 2279 - 2302
  • [45] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] A PROSPECTIVE COHORT STUDY OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH BEVACIZUMAB
    Naoki, Katsuhiko
    Soejima, Kenzo
    Nagase, Seisuke
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Takeda, Yuichiro
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S868 - S868
  • [47] Prevalence of EGFR Mutations in Brazilian Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
    Lima, Ellias Abreu
    Sales, Paulo Guilherme
    Vilaca, Israel
    Perillo, Fernanda
    Almeida, Flavia
    Martins, Graziella
    Goncalves, Mariana
    Toledo, Joseane
    Giovani, Poliana
    Silva, Wania
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1443 - S1444
  • [48] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [49] TIMELY REIMBURSEMENT: THE IMPACT OF EARLY ACCESS PROGRAMMES IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Webb, S.
    Mercure, J.
    VALUE IN HEALTH, 2023, 26 (12) : S263 - S263
  • [50] Management and treatment costs of non-squamous metastatic or locally advanced non-small cell lung cancer
    Pruszko, Cezary
    Jachimowicz, Michal
    Kalinowska, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (02): : 63 - 67